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Abstract
In mammalian physiology, lactation follows pregnancy. Disruption of this physiology is 
associated with long-term adverse maternal health outcomes, including higher risks of later life 
obesity, type 2 diabetes, metabolic syndrome, hypertension, and cardiovascular disease. Multiple 
mechanisms likely contribute to these associations, including the metabolic demands 
breastfeeding, modulation of stress reactivity, and confounding by other health behaviors. At the 
same time, evidence suggests that maternal metabolic health entering pregnancy affects lactation 
performance. In this paradigm, adverse lactation outcomes may be a marker for underlying 
maternal disease risk. Understanding these relationships has important clinical and policy 
implications for women's health.
Introduction
In mammalian physiology, lactation follows pregnancy. Breastfeeding provides the infant 
with specific and innate immune factors, as well as macro- and micronutrients, to support 
growth and development. To meet these nutritional needs, mothers expend approximately 
500 calories per day,1 deriving energy from their fat stores accumulated during pregnancy.
Disruption of this physiology is associated with adverse maternal health outcomes. In 
observational studies, lack of breastfeeding is associated with greater postpartum weight 
retention,2 and increased rates of later-life obesity,3 diabetes,4,5,6,7 hypertension,8,9 
metabolic syndrome,10,11 and cardiovascular disease.12,13. However, women with pregravid 
obesity are less likely to initiate and sustain breastfeeding,14,15 and recent work implicates 
insulin resistance in the pathogenesis of low milk supply.16,17,18 Thus, while breastfeeding 
may prevent development of the metabolic syndrome, preexisting metabolic dysregulation 
may also prevent breastfeeding.
Disentangling cause and effect has important implications for public health. To the extent 
that breastfeeding is a modifiable risk factor metabolic disease, strategies to enable women 
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to breastfeed may improve women's health. However, if metabolic disease is a risk factor for 
breastfeeding difficulties, women at metabolic risk may require additional support to enable 
them to meet their infant's nutritional needs.
This paper will review both human and animal studies linking lactation with maternal 
metabolic health, explore potential mechanisms, and discuss implications for clinical care 
and future research.
Lactation and maternal metabolic health
In observational studies, lactation is associated with differences in maternal metabolic 
health. Several authors have quantified this relationship among women with gestational 
diabetes, who are at increased risk of long-term metabolic disease. Kjos et al.19 compared 
postpartum glucose and lipid values among 809 Latina women with gestational diabetes. In 
models adjusted for age, body mass index, and insulin use during pregnancy, those who 
were breastfeeding at the time of their oral glucose tolerance test had lower fasting (93 ± 13 
vs. 98 ± 17 mg/dL, p <.01) and post-load (124 ± 41 vs. 134 ± 49 mg/dL, p<.01) glucose 
values at 4 to 12 weeks postpartum. Lactating women were less likely to have diabetes 
mellitus (4.2% vs. 9.4%, p=.01) and had higher HDL cholesterol, (48 ± 11 vs. 44 ± 10, p<.
01) compared with non-lactating women. Gunderson et al20 measured postpartum glucose 
tolerance among 522 women with gestational diabetes at 6–9 weeks postpartum. They found 
that women who were exclusively or mostly breastfeeding had lower fasting glucose levels 
than exclusively or mostly formula-feeding women, with a mean difference of about 5 
mg/dL. Two-hour post-load values were similar in breastfeeding and formula feeding 
mothers, but breastfeeding mothers had greater insulin sensitivity. In a secondary analysis 
among women who were lactating,21 the authors compared women who breastfed their 
infants during the 2-hour oral glucose tolerance test (OGTT) with those who did not. Fasting 
values were similar in the two groups, but women who breastfed during the OGTT had 
lower post-load glucose levels (mean difference −6.2, 95% CI −11.5, −1.0) as well as lower 
post-load insulin levels than those who did not. These results provide evidence that 
lactogenesis is associated with mobilization of glucose through non-insulindependent 
mechanisms.
The protective association between breastfeeding and metabolic disease appears to persist 
after weaning. Gunderson et al. measured the association between lifetime breastfeeding and 
development of metabolic syndrome among women in the CARDIA cohort study,10. Among 
women with a history of gestational diabetes, breastfeeding for >9 months was associated 
with a markedly lower risk of metabolic syndrome than breastfeeding 0–1 months. (MV-Adj 
OR 0.14, 95% CI 0.04–0.55), in models adjusting for baseline demographics, body mass 
index, metabolic syndrome components and physical activity. Ziegler at al22 measured 
progression to Type 2 Diabetes in a prospective cohort study of women with gestational 
diabetes in Germany (N=304). Among women who were islet-antibody negative (N=272), 
breastfeeding for at least 3 months was associated with a lower rate of progression to type 2 
diabetes (MV-Adj HR 0.54, 95% CI 0.34–0.85), compared with breastfeeding for ≤ 
3months.
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Lactation is similarly associated with reduced metabolic disease risk in the general 
population. Breastfeeding mobilizes approximately 500 kcal per day,1 and greater duration 
and intensity of breastfeeding is associated with reduced postpartum weight retention.2 In a 
randomized controlled trial of introduction of supplementary foods at 4 months vs. 
continued exclusive breastfeeding, women allocated to exclusive breastfeeding lost more 
weight than women allocated to supplementation, supporting a causal association between 
breastfeeding intensity and maternal weight loss.23
These differences in weight loss appear to persist after weaning. In the UK Millions Women 
Study, women who breastfed ≥ 6 months per birth had a lower BMI after menopause than 
women who breastfed < 6 months per birth, stratified by parity.3 Longer duration of 
breastfeeding is also associated with reduced central adiposity. In a secondary analysis of 
the Study of Women's Health Across the Nation (SWAN) cohort, Ram et al. found that 
longer lifetime breastfeeding duration was associated with smaller waist circumference, as 
well as lower prevalence of metabolic syndrome.11 McClure et al. analyzed a subset of the 
SWAN cohort that underwent CT-scans to evaluate subcutaneous and visceral adiposity.24 
They found that women who never breastfed or did not breastfeed each child at least 3 
months had greater visceral adiposity than women who consistently breastfed for > 3 months 
after each birth.
Longer lifetime lactation is also associated with lower incidence of type 2 diabetes. In the 
Nurses' Health Study cohorts, lifetime duration of lactation was associated with reduced 
likelihood of incident type 2 diabetes in the 15 years since a woman's last birth (HR per year 
of lifetime lactation, 0.85, 95% CI 0.73–0.99 in NHS and 0.86, 0.79–0.93 in NHS II).6 
Longer lactation has similarly been associated with reduced diabetes risk in the Women's 
Health Initiative,12 the Reproductive Risk factors for Incontinence Study at Kaiser,5 the 
Shanghai Women's Health Study,7 and the EPICPotsdam Study.4
Never or curtailed breastfeeding is also associated with an increased risk of incident 
hypertension. In the Nurses' Health Study II,9 breastfeeding the first child < 3 months was 
associated with a increased risk of incident hypertension, compared with ≥ 12 months of 
breastfeeding. Similar results have been reported among premenopausal women in Korea8 
and in the Women's Health Initiative.12 Lactation history is also associated with 
cardiovascular disease risk, with lower incidence of myocardial infarction in the Nurses' 
Health Study13 and reduced prevalent cardiovascular disease in the Women's Health 
Initiative.12
If these associations are causal, current suboptimal breastfeeding rates contribute to 
substantial morbidity for women's health. In a Monte Carlo Simulation Model, Bartick et 
al25 modeled burden of diabetes, hypertension and myocardial infarction for a hypothetical 
population of women born in a single year. Disease burden, premature death, and costs were 
modeled under optimal breastfeeding conditions, assuming that 90% of women breastfed for 
12 months after each birth, and under current conditions for the US population in 2008. In 
these models, suboptimal breastfeeding was associated with 53,847 excess cases of 
hypertension (95% CI 43,836 to 64,596), 4,482 excess cases of diabetes (95% CI −791 to 
8022) and 13,946 excess cases of myocardial infarction (95% CI 6318–21,090).
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Several mechanisms may explain the association between lactation duration and maternal 
health. The Reset Hypothesis26 (Figure 1) proposes that fat stores accumulate during 
pregnancy in anticipation of the metabolic needs of the lactating mother. When lactation 
does not occur, these metabolic changes persist, with adverse consequences for maternal 
health. This concept is consistent with evolutionary models suggesting that lactation evolved 
to allow mammals to nourish their young in the setting of unreliable food supplies.27 Animal 
models support a causal association between lactation and retained fat stores: in a murine 
model, dams who did not lactate had greater visceral, but not subcutaneous fat stores at 2 
months postpartum than dams who lactated.28
Lactation may also affect maternal health through effects on stress reactivity. Several studies 
have found that lactating women have reduced HPA-axis activation29 and greater vagal 
tone,29 compared with non-lactating women. These effects appear to vary with time since 
last feeding. In a study of lactating women, those who breastfed 30 minutes before a 
standardized social stressor had diminished HPA response, compared with women who 
breastfed 100 minutes before.30 Among mothers engaged in an aggression challenge task,31 
those who were breastfeeding had higher aggression levels, but lower systolic and diastolic 
blood pressure, than mothers who were formula feeding, suggesting that breastfeeding may 
be associated with reduced cardiovascular stress in the face of threat. To the extent that these 
differences persist after weaning, lactation may improve maternal health through moderation 
of stress reactivity.
Caveats
However, studies linking lactation with improved maternal health are confounded by other 
health factors. Mothers who breastfeed differ from mothers who formula feed; they are 
wealthier, better educated, less likely to smoke, and more likely to engage in other beneficial 
health behaviors.32,43,34 Thus, residual or unmeasured confounding, rather than 
breastfeeding itself, may explain observed associations between breastfeeding and health 
outcomes.
In addition, pre-pregnancy obesity is associated with reduced breastfeeding initiation and 
duration.14 In the Danish National Birth Cohort, Baker et al. found that overweight and 
obese women were more likely to discontinue full and any breastfeeding, adjusting for 
maternal age, parity, education, mode of delivery, and smoking during the postpartum 
period.15 Maternal obesity is also associated with delayed onset of lactogenesis following 
delivery,35 and with increased risk of disrupted lactation, defined as early, undesired 
weaning attributed to lactation dysfunction.36 Among normal BMI women, 9.0% 
experienced disrupted lactation, compared with 13.0% of overweight and 14.4 percent of 
obese women (MV-adjusted OR 1.52, 95% CI 1.06–2.17 for overweight; 1.73, 95% CI 
1.16–2.60 for obese women, compared with normal weight women).
Several mechanisms may play a role in associations between obesity and early cessation of 
breastfeeding. Maternal metabolic status during pregnancy may affect breast development. 
In a sample of women with polycystic ovary syndrome, Vanky et al37 found that women 
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with no breast growth in pregnancy, indexed by no change in bra size, had higher first 
trimester body mass index, systolic blood pressure, and fasting insulin, and they gained less 
weight during pregnancy. Women with no breast growth reported shorter duration of 
exclusive and any breastfeeding. Glucose homeostasis in the third trimester has also been 
correlated with feeding outcomes. In a small sample (N=16), insulin:glucose ratio and 
adiponectin measured at the time of the 28-week glucose loading test was associated with 
onset of milk production: women with a less favorable metabolic profile during pregnancy 
had later onset of lactogenesis,18 which is a risk factor for breastfeeding cessation.38 
Differences in insulin resistance may act at the level of the lactocyte. Lemay et al16 
compared gene expression in the milk fat globule transcriptome of women with and without 
low milk supply, and found differences in expression of PTPRF, which blocks the action of 
insulin to stimulate milk production. This action suggests a mechanism through which 
insulin resistance may contribute to reduced milk synthesis. Pituitary hormones may also 
play a role: Rasmussen et al39 found that pregravid overweight was associated with reduced 
prolactin response in the early postpartum period. Taken together, these data suggest that 
premature cessation of breastfeeding may be a marker for underlying metabolic 
dysregulation.
Perinatal depression and anxiety disorders may also mediate associations between lactation 
and maternal metabolic disease. Several authors have reported associations between 
perinatal depression and metabolic complications of pregnancy.40,41,42,43 Depression and 
anxiety are also associated with premature cessation of lactation.36,44 An underlying 
psychobiological vulnerability may, therefore, predispose women to both metabolic 
complications of pregnancy and early weaning.45
Among women with gestational diabetes, greater maternal glucose intolerance is associated 
with both infant and maternal breastfeeding difficulties. Bromicker et al. measured neonatal 
sucking patterns on day 3 of life among infants born to women with insulin-controlled 
GDM, diet-controlled GDM, and normal controls, and they found that exposure to insulin-
controlled GDM was associated with 5.2 fewer bursts and 42 fewer sucks during the 5-
minute observation period, compared with normal controls. In the Study of Women, Infant 
Feeding and Type 2 Diabetes after GDM pregnancy (SWIFT) cohort, Matias et al46 found 
that pregravid BMI > 30 kg/m2 and treatment of GDM with insulin were independently 
associated with delayed onset of lactogenesis. Interestingly, delayed lactogenesis was also 
associated with poor infant latch, suggesting that the differences in oromotor function may 
play a role in delayed onset of lactogenesis.
Implications for Clinical Care
In observational studies, longer duration of breastfeeding is associated with reduced risk of 
metabolic disease. Lactation mobilizes energy stores for the infant, and evidence from 
animal studies supports a causal effect of lactation on maternal metabolism. These data 
suggest that enabling women to breastfeed may facilitate weight loss and reduce metabolic 
disease risk.
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Several interventions have been tested to increase breastfeeding among high-BMI women. 
Chapman et al. randomized women with BMI ≥ 27 to a peer counselor intervention47 and 
found that women allocated to the intervention when compared to controls were more likely 
to be breastfeeding at 2 weeks, and their infants were less likely to be hospitalized in the 
first 6 months of life. There were no other differences in breastfeeding outcomes. Of note, 
control mothers could elect to enroll in the prenatal clinic's free lactation peer-support 
program. Carlsen et al. tested an International Board-Certified Lactation Consultants 
(IBCLC) phone support intervention for obese women in Denmark,48 and found that the 
intervention significantly increased duration of exclusive breastfeeding (median 120 days vs. 
41 days). Bonuck et al. tested an integrated pre- and post-natal IBCLC intervention among 
990 women, two-thirds of whom were overweight or obese.49 Lactation consultants met 
with mothers during 2 routine prenatal visits as well as during their maternity stay, and they 
contacted women by phone and provided home visits as needed after birth. The intervention 
increased rates of high-intensity breastfeeding at three months postpartum from 11 to 21%. 
These data suggest that proactive support of overweight and obese women may improve 
breastfeeding outcomes. Elements of the Bonuck breastfeeding intervention have been 
incorporated into an ongoing trial of a pre- and post-natal intervention to optimize outcomes 
among women with gestational diabetes.50
To enable women to breastfeed, maternity care providers should discuss a family's feeding 
plans early in prenatal care and provide practical anticipatory guidance and clinical care for 
breastfeeding complications, as needed.51 Providers should also facilitate maternity care 
practices that enable women to achieve their infant feeding goals, such as initiating 
breastfeeding within an hour of birth, giving only breast milk, rooming in, breastfeeding on 
demand, avoiding pacifiers, and fostering breastfeeding support groups after discharge.52
Such support is particularly important for women at increased risk of metabolic disease, 
given the association between obesity and breastfeeding difficulties. It may be helpful to 
emphasize the value of a nurturing relationship at the breast, in the event that exclusive 
breastfeeding is not possible. Maternal and pediatric care providers should coordinate care 
for these dyads with qualified lactation professionals, such as International Board-Certified 
Lactation Consultants. Embedding lactation consultants within obstetric and pediatric care 
may be sustainable now that the Affordable Care Act requires coverage of lactation support 
services.53
Implications for Future
Research Observational data demonstrate that pregravid metabolic risk factors, including 
insulin resistance and elevated body mass index, are associated with lower breastfeeding 
rates. Moreover, associations between early weaning and metabolic disease suggest that 
Adverse Lactation Outcomes (ALO), like Adverse Pregnancy Outcomes (APO), may be risk 
factors for future maternal metabolic disease. Research is needed to determine the 
mechanisms underlying these associations and to design and implement interventions that 
will enable more women to meet their infant feeding goals. Obstetric studies should 
routinely collect data on breastfeeding outcomes in order to advance this work. Such data 
should include standardized measures of breastfeeding intention,54 onset of lactogenesis,55 
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breastfeeding intensity,56 and reasons for weaning57 (Appendix). Incorporating assessment 
of lactation outcomes into epidemiologic studies is a prerequisite for determining the extent 
to which Adverse Lactation Outcomes predict long-term metabolic disease.
Translational research is also needed to define the physiologic mechanisms underlying lack 
of breast growth during pregnancy, delayed onset of lactogenesis and low milk production, 
which may mediate associations between maternal metabolic disease and early cessation of 
breastfeeding. The majority of research on mammary gland function has been performed in 
animals, and the extent to which these models apply to women is unclear, as detailed in a 
recent conference.17 Neville et al. note that research is imperative to "understand the 
mechanism by which obesity affects mammary gland development, milk secretion, and milk 
composition."
Conclusion
Both epidemiologic studies and animal models suggest that lactation may be a modifiable 
risk factor for maternal metabolic disease in later life. If this association is causal, 
investment in programs and policies that enable women to breastfeed may significantly 
improve women's health. Research is needed to elucidate the mechanisms linking premature 
weaning with maternal metabolic dysfunction, as well as to identify and implement 
strategies that enable women at metabolic risk to achieve their breastfeeding goals, thereby 
improving health across two generations.
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